Is legacy medical device patching draining hospital budgets?

AdvancedUNO
14 Jul, 2026
Is legacy medical device patching draining hospital budgets?

9 min read

At exactly 03:14 AM on a Tuesday, the clinical engineering team at a 320-bed regional hospital received an automated alert: the picture archiving and communication system (PACS) had stopped receiving images from the primary cardiovascular imaging suite. Within forty minutes, the diagnostic screens in the emergency department went dark. What began as a routine network anomaly quickly unfolded into a multi-day clinical diversion crisis, tracing back not to a sophisticated zero-day exploit, but to the compounding financial and operational debt of legacy medical device patching.

When the on-call security analyst investigated, they found the imaging console—a specialized workstation running an embedded, out-of-support version of Windows 7—attempting to establish thousands of concurrent outbound connections. The device had been compromised by a ransomware variant that had entered the hospital network through a phished administrative credential, subsequently scanning the flat internal network for vulnerable systems. Because the workstation was running a legacy operating system, it could not support modern endpoint detection and response (EDR) agents like CrowdStrike Falcon or SentinelOne, leaving the security team entirely blind to the initial lateral movement.

The chain of contributing causes behind this incident highlights the broken economic model of healthcare IoT. The manufacturer of the imaging suite had officially declared the software end-of-life in 2021, meaning no further operating system patches would be validated or provided. To upgrade the software to a supported version, the vendor demanded a proprietary hardware controller upgrade costing $145,000. Faced with a capital budget already squeezed by inflation and a 1.2% operating margin, the hospital’s clinical engineering department had opted to accept the risk, relying on perimeter firewalls that ultimately failed to stop internal lateral propagation.

How the lifecycle gap shifts security costs from vendors to providers

To understand why legacy medical equipment remains unpatched, one must follow the flow of capital and risk between Original Equipment Manufacturers (OEMs) and healthcare delivery organizations. OEMs capture high economic margins during the initial sale of capital medical equipment, which is physically engineered to last fifteen to twenty years. However, the commercial software and operating systems driving these machines typically have security lifecycles of only three to five years. Once that software lifecycle expires, the OEM has little financial incentive to invest engineering hours into backporting patches, choosing instead to use software obsolescence as a lever to force expensive hardware replacement cycles.

This dynamic leaves healthcare providers absorbing the entirety of the residual cyber risk and the operational costs of mitigation. When a vulnerability like Urgent/11 or Ripple20 is discovered in embedded TCP/IP stacks, hospitals cannot simply download a patch from the software vendor. They must wait for the medical device manufacturer to test, validate, and distribute the patch to ensure it does not interfere with the device’s clinical efficacy or void its regulatory clearances. When the manufacturer refuses to issue that patch, the hospital must fund expensive compensating controls, deploying specialized IoT security platforms such as Ordr, Armis, or Claroty Medigate to monitor and isolate the vulnerable assets.

The myth of the regulatory patch barrier

For years, medical device manufacturers have used the Food and Drug Administration (FDA) premarket approval process as a shield, claiming that applying security patches or updating operating systems would require a lengthy and costly re-clearance of the device. This is a persistent industry misunderstanding that continues to stall remediation efforts. The FDA has repeatedly clarified that routine cybersecurity patches and software updates do not typically require a new 510(k) submission, classifying them instead as software maintenance that actually mitigates safety risks.

"The economic asymmetry of medical IoT is stark: manufacturers capture the high-margin capital sales, while resource-constrained hospitals are left to fund the complex network fortresses required to keep those same devices from becoming entry points for ransomware."

The real bottleneck is not regulatory red tape, but rather the proprietary architecture of the devices themselves. Many medical systems are designed as closed black boxes where the hospital’s IT staff is legally and technically barred from accessing the underlying operating system. If a system administrator attempts to manually apply a Microsoft security patch to a vulnerable contrast injector console, they risk bricking the system and voiding the manufacturer's warranty, leaving the hospital liable for any subsequent clinical failures.

An autopsy of a legacy patch failure in clinical operations

To see how these competing incentives play out on the hospital floor, consider a representative composite scenario involving a fleet of older infusion pumps. These devices, purchased in 2016, rely on an unencrypted wireless protocol to receive drug library updates from a central server. The vulnerability allows an attacker on the same network to intercept traffic and modify dosage limits, presenting a direct threat to patient safety.

  1. The Vulnerability Disclosure: A security researcher publicizes a vulnerability affecting the legacy wireless module used in the infusion pumps. The manufacturer acknowledges the flaw but states that because the wireless chip supplier went out of business in 2022, no firmware patch will be developed.
  2. The Vendor's Remediation Proposal: The manufacturer offers a hardware upgrade program, allowing the hospital to trade in the legacy pumps for a new, secure model at a discounted rate of $1,200 per pump. For a health system managing 4,000 pumps, this represents an unbudgeted $4.8 million capital expenditure.
  3. The Defensive Isolation: Unable to afford the upgrade, the hospital CISO is forced to allocate internal engineering hours to build a dedicated, isolated wireless network solely for the legacy pumps. This requires configuring unique service set identifiers (SSIDs), implementing strict 802.1X authentication, and deploying network access control (NAC) policies to block the pumps from communicating with any system other than the drug library server.

Why standard enterprise patch management fails in clinical networks

  • The belief that automated vulnerability scanners can safely assess medical devices: Active network scanning tools like Nessus or Qualys can easily overwhelm the fragile, embedded network cards of legacy medical equipment. Running an active port scan against an older anesthesia machine or patient monitor can cause the device to crash, drop its network connection, or reboot mid-procedure, directly endangering patients.
  • The assumption that network segmentation is a permanent cure: While segmenting legacy devices onto isolated virtual local area networks (VLANs) is a critical defensive measure, it is not a set-and-forget solution. Clinical workflows frequently require these isolated devices to communicate with the broader hospital network—such as sending vitals to the electronic health record (EHR) system—creating tiny, authorized holes in the firewall that sophisticated malware can still traverse.
  • The expectation that cyber insurance will cover legacy neglect: Insurance underwriters are rapidly maturing their underwriting standards for healthcare systems. Carriers now routinely audit a hospital's inventory of legacy, unpatchable systems, and failing to demonstrate active compensating controls or a formal risk-acceptance sign-off can lead to denied coverage, astronomical deductibles, or the complete exclusion of claims arising from known, unpatched vulnerabilities.

Why the legacy installed base must be defended rather than replaced

It is easy for security purists to argue that hospitals should simply decommission any device that can no longer be patched. However, the operational reality of hospital finance makes this approach entirely untenable. Operating margins for non-profit health systems hover at historic lows, and a single diagnostic imaging suite can cost upwards of $2 million. Replacing a perfectly functional, clinically excellent MRI machine solely because the vendor refuses to patch its underlying operating system is a massive waste of capital that directly impacts a hospital’s ability to fund clinical staff and patient care programs.

Furthermore, the physical components of these legacy machines—the x-ray tubes, the mechanical gantries, the physical sensors—are often built to incredibly high standards and remain in pristine condition. The problem is not the physical machine, but the digital wrapper surrounding it. Therefore, defensive isolation, virtual patching through intrusion prevention systems (IPS), and strict access control lists (ACLs) are not just temporary workarounds; they are the only economically rational strategy for the next decade of healthcare operations.

The regulatory landscape is slowly shifting to address this imbalance, but the transition will take years. While the FDA’s updated guidance under Section 524B of the Federal Food, Drug, and Cosmetic Act now requires manufacturers to provide a Software Bill of Materials (SBOM) and a clear plan for security updates, this law is prospective [1]. It applies to new device submissions, leaving the massive, existing installed base of legacy devices currently running in hospitals across the nation entirely untouched [1]. Until policy addresses the retroactive security debt of these active clinical fleets, hospitals will continue to bear the financial burden of defending them.

Frequently Asked Questions

What is the legal liability for a hospital that manually patches a legacy medical device without OEM approval?

If a hospital applies an unauthorized software patch or operating system update to a medical device, it assumes full liability for any subsequent device malfunction or adverse patient event. Under FDA guidelines, the OEM is responsible for validating that software changes do not compromise the device's safety and effectiveness. By modifying the software independently, the hospital effectively becomes the "manufacturer" of the modified device in the eyes of regulators, potentially voiding its insurance coverage and exposing the organization to severe medical malpractice and product liability lawsuits.

How can we secure legacy devices that require obsolete protocols like SMBv1 to transmit clinical data?

Legacy devices that rely on obsolete, highly vulnerable protocols like SMBv1 or unencrypted HTTP should be placed on a strictly isolated VLAN with no direct access to the enterprise network or the internet. To facilitate data transfer to the PACS or EHR, hospitals should deploy a secure gateway or proxy server. This gateway acts as a protocol translator, accepting the insecure SMBv1 traffic within the isolated enclave, terminating the connection, and then re-transmitting the data to the production network using a secure, modern protocol like SMBv3 or HTTPS.

Does FDA Section 524B require manufacturers to provide SBOMs for devices purchased before 2023?

No, the cybersecurity requirements enacted under Section 524B are not retroactive [1]. The law applies to premarket submissions submitted to the FDA after the legislation took effect [1]. While some progressive manufacturers are voluntarily providing SBOMs for older systems to maintain positive customer relationships, there is currently no federal mandate forcing OEMs to generate SBOMs or develop security patches for legacy medical equipment already deployed in clinical settings [1].

If we isolate legacy devices on their own VLANs, how do we prevent lateral movement if those devices must still communicate with active directory or DNS servers?

Legacy medical devices should never point directly to enterprise-wide Active Directory (AD) or Domain Name System (DNS) servers, as these are primary targets during a ransomware outbreak. Instead, hospitals should configure localized, read-only domain controllers and dedicated, isolated DNS forwarders within the medical device network segment. These local services should be heavily restricted, allowing only the specific queries required for clinical operations, thereby preventing a compromised medical device from querying the entire corporate directory or traversing the domain trust to compromise enterprise credentials.

The Strategic Verdict: Managing legacy medical device patching requires moving away from the expectation of vendor-supplied fixes and toward a disciplined model of clinical micro-segmentation. Health systems must accept that they are the primary defenders of these vulnerable endpoints, leveraging specialized network visibility tools and strict protocol isolation to build defensive enclaves around unpatchable hardware. While this shifts the operational cost of security onto the provider, it remains the only viable path to protecting patient safety without forcing premature, multi-million-dollar capital equipment retirements.

Related from this blog

Sources

Next Post Previous Post
No Comment
Add Comment
comment url